Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Oct 04, 2018

SELL
$71.66 - $82.93 $2,293 - $2,653
-32 Closed
0 $0
Q2 2018

Jul 09, 2018

SELL
$58.93 - $74.24 $2,121 - $2,672
-36 Reduced 52.94%
32 $0
Q4 2017

Jan 23, 2018

BUY
$52.25 - $56.32 $3,553 - $3,829
68
68 $0

Others Institutions Holding CSLLY

About CSL LTD


  • Ticker CSLLY
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 964,432,000
  • Market Cap $84.7B
  • Description
  • CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plas...
More about CSLLY
Track This Portfolio

Track Central Trust CO Portfolio

Follow Central Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Central Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Central Trust CO with notifications on news.